Comen Elizabeth A
Department of Medicine, Memorial Sloan-Kettering Cancer Center, 301 East 66th Street, New York, New York 10065, USA.
Discov Med. 2012 Aug;14(75):97-104.
Metastasis, the process whereby cancer cells spread from their primary site of origin and grow in adjacent or distant sites, is the primary cause of death in cancer patients. The last 30 years has witnessed significant progress in decreasing cancer mortality rates--largely as a result of improved screening and prevention, practical applications of cancer genomics, and less toxic, more targeted therapies. Despite these improvements, metastasis relentlessly drives mortality. The pervasive mortality from metastasis highlights the shortcomings of traditionally accepted hypotheses on the metastatic process. Historically, metastasis has been described as a unidirectional process, whereby cancer cells leave a primary tumor and seed metastasis in regional lymph nodes or distant sites. This anatomically based hypothesis has dictated much of our medical, and in particular, surgical approach to treating cancers. Alternatively, recent research indicates that metastasis is a multidirectional process whereby cancer cells can seed distant sites as well as the primary tumor itself. The multidirectional pathway of cancer cells, termed "self-seeding," has been corroborated in several experimental and clinical models. This review will evaluate the "self-seeding" hypothesis with attention both to the "seed" (cancer cells) as well as the "soil" (premetastatic niche). Increasingly, the role of the microenvironment surrounding metastases appears essential to the survival of metastatic colonies. The self-seeding model depends not only on the inherent mobility of cancer cells, but also on the supporting non-cancerous cells which enable circulating tumors cells to migrate to and survive in distant sites. The recognition that some of these non-cancerous cells include key components of the immune system has re-ignited the field of immunotherapy in cancer. One particular area of immunotherapy research, tumor entrained neutrophils, will be reviewed in more depth. Ultimately, understanding the dynamic interplay between cancer cells and the metastatic niche offers fertile ground for progress both in the treatment and prevention of metastasis.
转移是指癌细胞从其原发部位扩散并在邻近或远处部位生长的过程,是癌症患者死亡的主要原因。过去30年见证了癌症死亡率下降方面的显著进展,这主要得益于筛查和预防的改善、癌症基因组学的实际应用以及毒性更小、更具针对性的疗法。尽管有这些进步,转移仍无情地导致死亡。转移导致的普遍死亡率凸显了传统上被接受的转移过程假说的缺陷。历史上,转移一直被描述为一个单向过程,即癌细胞离开原发性肿瘤并在区域淋巴结或远处部位形成转移灶。这种基于解剖学的假说在很大程度上决定了我们治疗癌症的医学方法,尤其是手术方法。相比之下,最近的研究表明,转移是一个多向过程,癌细胞不仅可以在远处部位形成转移灶,还能在原发性肿瘤自身形成转移灶。癌细胞的这种多向途径,即“自我播种”,已在多个实验和临床模型中得到证实。本综述将评估“自我播种”假说,同时关注“种子”(癌细胞)和“土壤”(前转移微环境)。越来越多的证据表明,转移灶周围微环境的作用对于转移瘤的存活至关重要。自我播种模型不仅依赖于癌细胞固有的迁移能力,还依赖于支持性的非癌细胞,这些细胞使循环肿瘤细胞能够迁移到远处部位并在那里存活。认识到其中一些非癌细胞包括免疫系统的关键成分,重新点燃了癌症免疫治疗领域的研究热情。免疫治疗研究的一个特定领域,即肿瘤诱导中性粒细胞将得到更深入的综述。最终,了解癌细胞与转移微环境之间的动态相互作用为转移的治疗和预防取得进展提供了肥沃的土壤。